A Prospective Study of Allogeneic Transplant for Older Patients with Acute Myelogenous Leukemia (AML) Indicates that Unrelated Donor Transplants are as Efficacious as Related Donor, with Favorable Outcomes for Intermediate Risk Disease Gregory Yanik, John Magenau, Steven C. Goldstein, Attaphol Pawarode, Moshe Talpaz, John Levine, Sung Choi, Carrie L. Kitko, Daniel R. Couriel Biology of Blood and Marrow Transplantation Volume 19, Issue 2, (February 2013) DOI: 10.1016/j.bbmt.2012.11.284 Copyright © 2013 Terms and Conditions
Figure 1 Biology of Blood and Marrow Transplantation 2013 19, DOI: (10.1016/j.bbmt.2012.11.284) Copyright © 2013 Terms and Conditions